Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor and Aspirin in COPD for CVD Prevention
NCT03487406Phase 2Completed
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Sep 2015
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ticagrelor in cardiovascular disease (CVD), sponsored by Newcastle Hospitals NHS Foundation Trust. Started Sep 2015; status: completed.
02
Drugs
ticagrelor
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT03487406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03487406.